Dr.rer.nat.,Postdoctoral researcher - investigating pharmacological modulations of host-pathogen interactions with a special focus on lipid mediators. #WerzLab
Jena, Deutschland
Joined September 2020
- Tweets87
- Following132
- Followers172
- Likes249
Pinned Tweet
I'm so happy that my current research stay at the Harvard Medical School, Brigham and Women's Hospital under supervision @CNSerhanLab is supported by the @microverse_exc Scientist Exchange Fund (SEF). Thank you! #lipidmediators #harvardmedicialschool #inflammation #resolution
Paul M. Jordan retweeted
Great joint meeting FungiNet & IMIHM! 🌟Amazing discussions and inspiring talks. 🙌Thanks to all of you!
I'm so happy to share our new paper about novel potent and selective mPGES-1 inhibitors for the treatment of inflammation, pain, and fever, which we just recently published in the Journal of Medicinal Chemistry! pubs.acs.org/doi/10.1021/acs…
Paul M. Jordan retweeted
Time for interdisciplinary #LIFEScience CONNECTions! 🦠📷
LIFE offers funding through the "Connect" fund and more. Meet researchers and network with local companies & intitatives at the 3rd LIFE Symposium!
🗓️Nov 6, 2024
🔗kurzlinks.de/LIFESymposium
@UniJena
@uniklinik_jena
Check out our new protocol for lipid mediator profiling in human macrophages during host-pathogen interaction, published in STAR protocols. #lipidmediators #macrophags star-protocols.cell.com/prot…
I'm happy to share our new work about the fungal toxin gliotoxin, which modulates macrophage activation and lipid mediator networks. Thanks for all the contributions within the @TRR_FungiNet consortium.
onlinelibrary.wiley.com/doi/…
Paul M. Jordan retweeted
I'm excited to have this out in the world. Kudos to Rachel Grazda 🎉! We pursued the curious link between IFNg-dependent monopoiesis that accompanies bone marrow failure, and we began by asking why aren't dead cells being cleared? nature.com/articles/s41419-0… – at New York, USA
We have wonderful news, our boswellia serrata project goes on! We have a new manuscript in Frontiers Pharmacology. We found that Frankincense extracts could modulate lipid mediator biosynthesis in innate immune cells. #inflammation #resolution
frontiersin.org/articles/10.… – at Jena, Germany
Paul M. Jordan retweeted
Happy to share a review @CNSerhanLab and I have been working on highlighting the importance of inflammation resolution in vascular inflammation and atherosclerotic CVD! @NatRevCardiol @AlbanyMed @AlbanyMedMCP
New review highlights the importance of inflammation resolution (or the lack thereof) in atherosclerotic cardiovascular disease, pinpointing potential targets for therapeutic modulation
nature.com/articles/s41569-0… @NatRevCardiol @GabbyFredman @CharlesSerhan
Yes!!! a long time ago, we started that project and finally it could be published in iScience. We investigated the impact of Influenza A virus on lipid mediator formation in human macrophages. Have a look:) – at Jena, Germany
Paul M. Jordan retweeted
Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators by Peltner, Werz, @PMJordan92, et al at @LSU_BioSci @UninaIT @UniJena @UniAvogadro dlvr.it/T0RtmB
Paul M. Jordan retweeted
As a community we believe that in a time where misinformation has negatively affected public opinion around many important topics it is a essential that facts are presented in a balanced and unbiased manner in Scientific journals @ScienceMagazine
Yesterday, the 2nd LIFE Symposium took place. So many different and amazing presentations. Thanks a lot for funding my mast cell research with the LIFETalent fund to the amount of 4000€! @profillinie @UniJena – at Jena, Germany
Paul M. Jordan retweeted
A big thank you to all participants, keynote speakers, talk and poster presenters, and everyone who made our #FungiNet meeting such an inspiring event! See you next time!
Paul M. Jordan retweeted
Online now! Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators by Peltner, Werz, @PMJordan92, et al at @LSU_BioSci @UninaIT @UniJena @UniAvogadro #chembiol dlvr.it/SvLpn5
Paul M. Jordan retweeted
New Research: Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators #pharmacology frontiersin.org/articles/10.…
Paul M. Jordan retweeted
🎉 Exciting news! Our latest open access publication in ACS Omega explores "Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5‑Lipoxygenase-Activating Protein" 🧪 These compounds could be a new class of anti-inflammatory agents.
Wow, what a fantastic moment in life - I received the doctoral thesis award 2023 from the Friedrich-Schiller-Universität Jena for my dissertation and could introduce the university to my scientific topics with a talk. #lipidmediators #bacterialinfection #Unijena
©Jens Meyer
Online now! Happy to share with you a new manuscript in EJMC to which I could contribute. We investigated new multi-action Pt(IV) prodrugs conjugated with NSAIDs for anticancer therapy with anti-inflammatory properties. #COX #PGE2 #anticancer #NSAID
sciencedirect.com/science/ar…